关于多药预防心血管疾病临床结果的元分析
Ramy Sedhom1, Mohamed Hamed2, Weiyi Tan3
1Division of Cardiology, Loma Linda University Medical Center, Loma Linda, California.
The American journal of cardiology
|June 29, 2023
概括
在心血管疾病预防中,多药丸治疗显著降低了主要心脏和脑血管不良事件 (MACCEs) 的风险. 这一策略改善了坚持并降低了心血管死亡率,而不会增加不良事件.
科学领域:
- 心脏病学 心脏病学
- 预防医学 预防医学
- 药物治疗 药物治疗
背景情况:
- 心血管疾病 (CVD) 仍然是全球主要的死亡原因.
- 多药丸疗法,即将多种药物结合成一个单一的药丸,旨在简化治疗方案.
- 之前关于预防心血管疾病的多药药疗效的随机对照试验 (RCT) 显示了不一致的结果.
研究的目的:
- 系统地评估多药药疗法的有效性和安全性,用于心血管疾病的初级和二级预防.
- 综合RCT的数据,以确定多药对主要心脏和脑血管不良事件 (MACCEs) 的影响.
主要方法:
- 针对截至2023年1月的RCT进行了电子文献搜索.
- 包括的研究重点是用于初级或二级心血管疾病预防的多药丸使用.
- 评估的主要结果是MACCE的发病率,其次要结果包括心血管死亡率,心肌梗塞,中风和坚持.
主要成果:
- 分析了11个涉及25389名患者的RCT.
- 多药丸治疗与MACCEs风险降低有关 (RR 0.78,95% CI 0.67-0.91).
- 观察到心血管死亡率,心肌梗塞和中风的显著降低,患者坚持治疗改善,严重不良事件没有增加.
结论:
- 多药丸治疗是减少心脏事件的有效策略,既能预防初级心血管疾病,也能预防二级心血管疾病.
- 观察到的好处包括较低的MACCE发病率,改善的坚持,以及没有增加的安全问题.
- 这种方法为改善心血管健康结果提供了一种有希望的方法.
更多相关视频
08:36Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
Published on: April 19, 2024
607
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.4K
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
566
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
566
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
01:26Coronary Artery Disease IV: Preventive Measures
25
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
25
01:26Atherosclerosis III: Management
13
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
13
01:12Hazard Ratio
165
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
165
01:27Coronary Artery Disease V: Interprofessional Care
10
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
10